Work

Steroid-Sparing Effects of Anti-IL-5 Monoclonal Antibody (Mepolizumab) Therapy in Patients with HES: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Year: 2006

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.373.373

Authors: Marc E. Rothenberg, Gerald J. Gleich, Florence E. Roufosse, Lanny J. Rosenwasser, Peter F. Weller

Institutions: Cincinnati Children's Hospital Medical Center, University of Cincinnati, University of Utah, Université Libre de Bruxelles, Erasmus Hospital, Children's Mercy Hospital, Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: Eosinophilic Disorders and Syndromes

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2594054128

FWCI: 1.668

Cites:

Cited by: 11

Related to: 10